Keyphrases
Glucose-dependent Insulinotropic Polypeptide
90%
Glucagon-like
56%
Glucagon
35%
Receptor Antagonist
30%
GIP Receptor
27%
Healthy Individuals
26%
Glucos
26%
Insulin Secretion
26%
Glucose Effect
25%
Competitive Antagonist
25%
C-C Chemokine Receptor Type 5 (CCR5)
25%
Rodents
20%
Fibroblast Growth Factor 21 (FGF21)
17%
G Protein
16%
Insulin
15%
Type 2 Diabetic Patients
15%
Transmembrane Helix
15%
Pharmacology, Toxicology and Pharmaceutical Science
Gastric Inhibitory Polypeptide
100%
Gastric Inhibitory Polypeptide Receptor
53%
Glucagon-Like Peptide-1
51%
Placebo
45%
Receptor Antagonist
31%
Receptor
30%
Obesity
25%
Guanine Nucleotide Binding Protein
20%
Non Insulin Dependent Diabetes Mellitus
15%
Biochemistry, Genetics and Molecular Biology
Gastric Inhibitory Polypeptide
81%
Gastric Inhibitory Polypeptide Receptor
39%
G Protein
28%
Receptor Antagonist
26%
CCR5
25%
Insulin Release
22%
Glucagon
21%
Glucagon-Like Peptide-1
20%
Glucose Blood Level
17%